ID: ALA89063

Max Phase: Preclinical

Molecular Formula: C5H7NO5

Molecular Weight: 161.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)CCNC(=O)C(=O)O

Standard InChI:  InChI=1S/C5H7NO5/c7-3(8)1-2-6-4(9)5(10)11/h1-2H2,(H,6,9)(H,7,8)(H,10,11)

Standard InChI Key:  MUEINUJSOJHERH-UHFFFAOYSA-N

Associated Targets(non-human)

P4ha1 Prolyl 4-hydroxylase alpha-1 subunit (36 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 161.11Molecular Weight (Monoisotopic): 161.0324AlogP: -1.34#Rotatable Bonds: 3
Polar Surface Area: 103.70Molecular Species: ACIDHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.50CX Basic pKa: CX LogP: -1.13CX LogD: -7.86
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.44Np Likeness Score: -0.06

References

1. Cunliffe CJ, Franklin TJ, Hales NJ, Hill GB..  (1992)  Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivatives.,  35  (14): [PMID:1321909] [10.1021/jm00092a016]

Source